Kurs
+2,31%
Kurs
+2,31%
Open
1,50
High
2,40
Low
1,32
Close
1,33
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Kalender
| Est. tid* | ||
| 2025-08-29 | 12:20 | Kvartalsrapport 2025-Q2 |
| 2025-07-03 | N/A | Extra Bolagsstämma 2025 |
| 2025-05-30 | - | X-dag ordinarie utdelning OBSRV 0.00 NOK |
| 2025-03-18 | - | Bokslutskommuniké 2024 |
| 2025-01-14 | - | Split OBSRV 15:1 |
| 2024-08-26 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-27 | - | X-dag ordinarie utdelning OBSRV 0.00 NOK |
| 2024-05-24 | - | Årsstämma |
| 2024-03-13 | - | Bokslutskommuniké 2023 |
| 2023-11-22 | - | Extra Bolagsstämma 2023 |
| 2023-08-25 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-30 | - | X-dag ordinarie utdelning OBSRV 0.00 NOK |
| 2023-05-26 | - | Årsstämma |
| 2023-02-17 | - | Bokslutskommuniké 2022 |
| 2022-11-03 | - | 15-10 2022-Q3 |
| 2022-08-25 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-03 | - | X-dag ordinarie utdelning OBSRV 0.00 NOK |
| 2022-06-03 | - | Årsstämma |
| 2022-03-29 | - | Bokslutskommuniké 2021 |
| 2022-02-04 | - | Extra Bolagsstämma 2022 |
| 2021-11-03 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-20 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-25 | - | X-dag ordinarie utdelning OBSRV 0.00 NOK |
| 2021-05-21 | - | Årsstämma |
| 2021-05-12 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-23 | - | Bokslutskommuniké 2020 |
| 2020-11-03 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-18 | - | Kvartalsrapport 2020-Q2 |
| 2020-07-01 | - | X-dag ordinarie utdelning OBSRV 0.00 NOK |
| 2020-06-30 | - | Årsstämma |
| 2020-06-16 | - | Extra Bolagsstämma 2020 |
| 2020-05-12 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-25 | - | Bokslutskommuniké 2019 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | OAX Equities |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2025-06-27 10:16:16
Observe Medical ASA - Disclosure of voting rights at the Annual General meeting
Oslo, 27 June 2025: In connection with the annual general meeting of Observe Medical ASA (the "Company") to be held on 27 June 2025 (the "AGM"), Terje Bakken, chairman of the board of directors of the Company, has received proxies without voting instructions for 6,247,342 shares or 32.44% of the total shares and voting rights in the Company. The proxies are only valid at the AGM.
This information is subject to the disclosure requirements pursuant to section 4 -2 of the Norwegian Securities Trading Act.